🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, dose escalation, phase I study of the combination of...
Status
Withdrawn
Location
Dartmouth-Hitchcock Medical Center
Start Date
2016-08
Trial ID
NCT03422874
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Terminated
Location
Multiple Locations
Start Date
2012-06-05
Trial ID
NCT04272775
Treatments Being Tested
The primary purpose of the trial is to determine the safety and tolerabilit...
Status
Completed
Location
Mayo Clinic
Start Date
2017-03-20
Trial ID
NCT02946047
Treatments Being Tested
The purpose of this study is to evaluate the effects, good and bad of a new...
Status
Unknown
Location
Northwestern University
Start Date
2015-10-28
Trial ID
NCT02481310
The purpose of this study is to evaluate the percentage of participants wit...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2018-03-13
Trial ID
NCT03439293
Treatments Being Tested
Light chain (AL) amyloidosis is a bone marrow disorder that affects a wide ...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2017-06-12
Trial ID
NCT03236792
Treatments Being Tested
The purpose of this study is to determine the long-term safety and tolerabi...
Status
Completed
Location
Beijing Chaoyang Hospital Capital Medical University
Start Date
2019-01-24
Trial ID
NCT03748953
Treatments Being Tested
This is a Phase I/II trial of the combination pegylated IFN-alpha 2b with i...
Status
Terminated
Location
Fox Chase Cancer Center
Start Date
2015-08-14
Trial ID
NCT02447887
Treatments Being Tested
This is a single arm open label phase 2 study evaluating the potential effe...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-03-10
Trial ID
NCT03082677
Treatments Being Tested